Physician profile
Charla Smith
NPI 1952773269
$1,155.34
in general payments reported to CMS, 2019-2025
17 companies · $253 in 2025
The $253 reported for 2025 was more than what 86% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $287 · 2022: $291 · 2023: $203 · 2024: $122 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $327.49 | 2021-2023 | Slynd |
| Hologic Sales and Service, LLC | $167.50 | 2021-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Aptima |
| Abbvie INC. | $144.55 | 2021-2022 | |
| Shield Therapeutics INC | $78.17 | 2023-2025 | Accrufer |
| Evofem Biosciences, INC. | $73.96 | 2021-2023 | Phexxi |
| Baxter Healthcare | $69.52 | 2025 | Perclot |
| Coopersurgical, INC. | $38.81 | 2021-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $37.28 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $35.27 | 2025 | |
| Millicent US INC | $32.42 | 2025 | Femlyv |
| Mylan Pharmaceuticals INC. | $30.38 | 2021 | |
| Dexcom, INC. | $28.85 | 2025 | Dexcom G6 Transmitter |
| Organon LLC | $23.07 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.81 | 2023 | |
| Pfizer INC. | $16.95 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $16.77 | 2024 | Veozah |
| Medtronic, INC. | $15.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charla Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.